Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy
Joint Authors
Hua, Ping
Liu, Jian-Yang
Tao, Jun
Yang, Song-Ran
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-07-29
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Treatment of ischemic cardiomyopathy caused by myocardial infarction (MI) using mesenchymal stem cell (MSC) transplantation is a widely researched field, with promising clinical application.
However, the low survival rate of transplanted cells has a severe impact on treatment outcome.
Currently, research is focused on investigating the strategy of combining genetic engineering, tissue engineering materials, and drug/hypoxia preconditioning to improve ischemic cardiomyopathy treatment outcome using MSC transplantation treatment (MSCTT).
This review discusses the application and progress of these techniques.
American Psychological Association (APA)
Hua, Ping& Liu, Jian-Yang& Tao, Jun& Yang, Song-Ran. 2015. Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy. BioMed Research International،Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1055942
Modern Language Association (MLA)
Hua, Ping…[et al.]. Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy. BioMed Research International No. 2015 (2015), pp.1-6.
https://search.emarefa.net/detail/BIM-1055942
American Medical Association (AMA)
Hua, Ping& Liu, Jian-Yang& Tao, Jun& Yang, Song-Ran. Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1055942
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1055942
